Evolving Trends in Female to Male Incidence and Male Mortality of Primary Biliary Cholangitis
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Primary biliary cholangitis (PBC) has been regarded as female-predominant without evidence of gender difference in survival. We aimed to compare the overall survival, incidence and prevalence of PBC in two well defined population-based studies over a recent decade, considering also sex ratios and mortality. We have taken advantage of population-wide records, during 2000–2009, in Lombardia, Northern Italy and Denmark. We focused on the incident cases of PBC, including gender and outcome, among 9.7 million inhabitants of Lombardia and 5.5 million of Denmark. In Lombardia there were 2,970 PBC cases with a female:male ratio of 2.3:1. The age/sex-adjusted annual incidence of PBC was 16.7 per million. Point prevalence was 160 per million on January 1 st 2009. In Denmark there were 722 cases of incident PBC, female:male ratio was 4.2:1 and the annual incidence was 11.4 per million, a point prevalence of 115 per million in 2009. Cox regression multivariate analysis identified male sex as an independent predictor of all-cause mortality in both Italian (HR 2.36) and Danish population (HR 3.04). Our data indicate for PBC a sex ratio significantly lower than previously cited, a reversal of the usual latitudinal difference in prevalence and a surprisingly higher overall mortality for male patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“although some recent data suggest an increasing male prevalence [18]; the female predominance of PBC continues to be unexplained [19].”
From EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“The disease is female predominant (as confirmed by large registry efforts)”
From EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Danish National Hospital Register. A valuable source of data for modern health sciences.
Andersen, T. F., Madsen, M., Jørgensen, J. O. L., Mellemkjoer, L., & Olsen, J. H. (1999) · PubMed · Cited by 2,026
Kaplan, M. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702263160907 · Cited by 1,959
AGE STANDARDIZATION OF RATES: A NEW WHO STANDARD
Ahmad, O. B., Boschi-Pinto, C., López, A. D., Murray, C. J. L., Lozano, R., & Inoue, M. (2000) · Cited by 1,957
The Danish Civil Registration System. A cohort of eight million persons.
Pedersen, C. B., Gøtzsche, H., Møller, J. O., & Mortensen, P. B. (2006) · PubMed · Cited by 1,617
Sex differences in autoimmune disease
Whitacre, C. C. (2001) · Nature Immunology · doi:10.1038/ni0901-777 · Cited by 1,271
(2011) · Encyclopedia of Cancer · doi:10.1007/978-3-642-16483-5_4730 · Cited by 1,240
Kaplan, M. M., & Gershwin, M. E. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043898 · Cited by 1,144
Self-citationWhen an Entire Country Is a Cohort
Frank, L. (2000) · Science · doi:10.1126/science.287.5462.2398 · Cited by 864
(2015) · Diagnostic Imaging: Gastrointestinal · doi:10.1016/b978-0-323-37755-3.50202-6 · Cited by 811
Parés, A., Caballería, L., & Rodés, J. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.12.029 · Cited by 756
Cited by
Items 101–186 of 186
Primary Biliary Cholangitis Overlap With Autoimmune Hepatitis? A Case Report
Costa, V., Moreira, M., Costa, R., & Fontes, J. (2021) · Journal of Medical Cases · doi:10.14740/jmc3623 · Cited by 6
Yehezkel, E., Israel, I., Houri, I., Leshno, M., Shibolet, O., & Zigmond, E. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10194551 · Cited by 6
Bager, P., Bossen, L., Gantzel, R. H., & Grønbæk, H. (2024) · PLoS ONE · doi:10.1371/journal.pone.0301354 · Cited by 7
“PBC is a rare disease [4] with approximately 90% being women aged between 30 to 65 years at the time of diagnosis [3].”
BackgroundTanaka, A., Leung, P. S. C., Young, H. A., & Gershwin, M. E. (2017) · Archives of Medical Science · doi:10.5114/aoms.2017.70995 · Cited by 7
“To understand the importance of developing a useful mouse model, other aspects of PBC such as spectra of disease and gender dominance should be considered [18, 31].”
BackgroundSelf-citationPBC: No Longer a Western Disease?
Tanaka, A. (2020) · Clinical Liver Disease · doi:10.1002/cld.903 · Cited by 7
ComputAgeBench: Epigenetic Aging Clocks BenchmarkPreprint
Kriukov, D. V., Efimov, E., Kuzmina, E., Dudkovskaia, A., Khrameeva, E. E., & Dylov, D. V. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.06.597715 · Cited by 7
Pohl, J., Walia, N., Hofmann, L., Wolters, L., Schulz, M. S., Reinhardt, M., Globke, B., Tacke, F., Berg, T., & Engelmann, C. (2025) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.70287 · Cited by 5
“This suggests men with PBC may be more likely to be hospitalised or experience more severe disease than women [30].”
Sex Hormones and the Liver: Implications for Disease Progression and Hormonal Therapy
Cazzagon, N., Gambato, M., Brunetto, M. R., Villa, E., Burra, P., & Floreani, A. (2026) · Liver International · doi:10.1111/liv.70509 · Cited by 10
“However, recent studies suggest that this ratio may be lower than previously reported [132].”
Mínguez, A., Amiel, I. C., Abia, P. L., Delgado, S. M., Pérez, Á. C., & Berenguer, M. (2021) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2021.03.017 · Cited by 5
Selected Aspects of the Intricate Background of Immune-Related Cholangiopathies—A Critical Overview
Kasztelan‐Szczerbińska, B., Rycyk, A., Szczerbińska, A., & Cichoż‐Lach, H. (2023) · Nutrients · doi:10.3390/nu15030760 · Cited by 6
“However, currently, growth is observed in male incidence [19,22].”
BackgroundSahu, R., Mishra, R., & Majee, C. (2020) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2020.1797485 · Cited by 5
“However, other studies have reported lower ratios of 2–5 to 1 [11,14].”
BackgroundChen, C., Cheng, J., Wang, H.-E., Huang, C.-W., Hu, J., Chen, W., Chang, M., Ku, H. T. S., Lin, C.-Y., Chien, R., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112226 · Cited by 5
“Although the median female-to-male ratio in the population with PBC is generally accepted to be 10:1 [4], a declining trend in the female-to-male ratio in patients with PBC had been reported recently [15], and it has been suggested that PBC may have been under-diagnosed in men in early studies.”
BackgroundMethodInfluentialPrimary biliary cholangitis: Diagnosis and treatment
Chew, M. T., & Bowlus, C. L. (2018) · Liver Research · doi:10.1016/j.livres.2018.03.004 · Cited by 6
Carbone, M., Bonato, G., & Invernizzi, P. (2017) · Hepatology · doi:10.1002/hep.29625 · Cited by 5
“Although more recent studies based on administrative data are challenging this concept by showing lower F:M ratios,((1)) PBC still remains a strongly female preponderant disease.”
Self-citationAn update on novel investigational agents for the treatment of primary biliary cholangitis
Floreani, A., Gabbia, D., & Martin, S. D. (2025) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2025.2573638 · Cited by 4
“Indeed, the F/M ratio has been recently reported closer to 4–6:1 [3,4].”
The prevalence and disease course of autoimmune liver diseases in Greenland
Gantzel, R. H., Bagge, C. N., Villadsen, G. E., Rex, K. F., Grønbæk, H., & Pedersen, M. L. (2024) · International Journal of Circumpolar Health · doi:10.1080/22423982.2024.2327693 · Cited by 6
“The prevalence of PBC in Greenland was 5.3 per 100,000 which is also lower than most Nordic countries including Denmark (11.5 per 100,000) and the Faroe Islands (38.5 per 100,000) and among Inuit in Alaska (18 per 100,000) [10,25–27].”
BackgroundInfluentialA Mouse Model of Autoimmune Cholangitis via Syngeneic Bile Duct Protein Immunization
Ma, W.-T., Liu, Q.-Z., Yang, J.-B., Yang, Y., Zhao, Z.-B., Ma, H.-D., Gershwin, M. E., & Lian, Z. (2017) · Scientific Reports · doi:10.1038/s41598-017-15661-6 · Cited by 4
Self-citationRoles of Non-Coding RNAs in Primary Biliary Cholangitis
Zhang, Y., Jiao, Z., Chen, M., Shen, B., & Shuai, Z. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.915993 · Cited by 4
Wu, J., Fan, X., & Song, Y. (2023) · Digestive and Liver Disease · doi:10.1016/j.dld.2023.02.020 · Cited by 9
Gerussi, A., Carbone, M., & Invernizzi, P. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15095 · Cited by 4
Self-citationGadour, E., Miutescu, B. P., Bashir, H., Ali, A. A., Al-Anzi, S. K., Al-Shahrani, A., Almuhaidb, A., Mohamed, S., Abaalkhail, F. A., Kuriry, H., et al. (2025) · Pharmaceuticals · doi:10.3390/ph18050697 · Cited by 3
“However, recent data indicate an increasing incidence in adult men, reducing the female-to-male ratio to 4–6:1 [6–8].”
Hypercholesterolemia of Cholestasis
Charlat, M., Poltiyelova, E., Silverman, J., Lit, A., Frishman, W. H., & Lebovics, E. (2025) · Cardiology in Review · doi:10.1097/crd.0000000000000994 · Cited by 3
Buechter, M., Manka, P. P., Bulut, K., Gerken, G., & Kahraman, A. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15030079 · Cited by 5
“Its incidence ranges between 0.9 and 5.8 per 100,000 population per year, while its prevalence is 1.9–40.2 per 100,000 [1,2,8].”
InfluentialHe, Q., Jiang, M., Wang, Y., & Zheng, T. (2025) · British Journal of Clinical Pharmacology · doi:10.1002/bcp.70186 · Cited by 3
“2 3 – 5 Most PBC patients have no obvious symptoms and are characterized by only a few biochemical abnormalities such as increased alkaline phosphatase (AKP) levels and the presence of anti-mitochondrial antibodies in the early stages of the disease.”
Mínguez, A., Amiel, I. C., Abia, P. L., Delgado, S. M., Pérez, Á. C., & Berenguer, M. (2022) · Gastroenterología y Hepatología (English Edition) · doi:10.1016/j.gastre.2021.03.014 · Cited by 3
Prevalence of Primary Biliary Cholangitis in a Cohort of Primary Sjögren’s Syndrome Patients
Santos, G. A., Brandão, M., & Farinha, F. (2022) · Cureus · doi:10.7759/cureus.24590 · Cited by 3
“Primary biliary cholangitis (PBC), previously known as primary biliary cirrhosis, is the most common autoimmune liver disease reflected histopathologically by a chronic immune-driven injury to the small bile ducts [6-8].”
BackgroundPerez, C. F. M., Gerussi, A., Trivedi, P. J., Corpechot, C., van der Meer, A. J., Battezzati, P. M., Lindor, K. D., Nevens, F., Kowdley, K. V., Bruns, T., et al. (2022) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002464 · Cited by 3
Self-citationTu, Z., Wang, Y., Wang, Y., Huang, J., Han, Y., Ji, Q., Cao, X., Wen, X., Wang, Y., & Jin, Q. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1152294 · Cited by 4
“Compared with the previous understanding that the ratio was about 1:9, this result is closer to the recent epidemiological findings (1:5-1:6) (39, 40).”
ResultLiang, E., Liu, M., Ke, P.-F., Han, G., Zhang, C., Deng, L. F., Wang, Y., Huang, H., Huang, W., Liu, R., et al. (2023) · Laboratory Medicine · doi:10.1093/labmed/lmad018 · Cited by 4
Blaga, T. S., Caragut, R.-L., Caraiani, C., Sparchez, Z. A., Hajjar, N. A., & Dumitrascu, D. L. (2023) · Journal of Medical Case Reports · doi:10.1186/s13256-023-03932-y · Cited by 3
“Women are more affected by PBC, with a female: male ratio of 10:1 [3].”
BackgroundMedina‐Morales, E., Ismail, M., Barba, R., Abboud, Y., Sierra, L., Marenco‐Flores, A., Goyes, D., Saberi, B., Patwardhan, V. R., & Bonder, A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12206536 · Cited by 5
“PBC tends to manifest in older men with more severe disease [1,4].”
BackgroundAdverse events associated with obeticholic acid: a real-world, pharmacovigilance study
Zhang, C., & Wang, J. (2025) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2025.2487144 · Cited by 2
Zen, Y., Hübscher, S. G., & Nakanuma, Y. (2023) · Elsevier eBooks · doi:10.1016/b978-0-7020-8228-3.00009-0 · Cited by 3
Geoepidemiology and the key role of sex chromosomes on autoimmune diseases
Lleò, A. (2023) · Principles of Gender-Specific Medicine · doi:10.1016/b978-0-323-88534-8.00051-1 · Cited by 3
Cho, J. M., Koh, J. H., Kim, S. G., Lee, S., Kim, Y., Cho, S., Kim, K., Kim, Y. C., Han, S. S., Lee, H., et al. (2023) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16355 · Cited by 2
Primary Biliary Cholangitis in Elderly: About 12 Tunisian Cases
Lamine, Z. B., Mankaï, A., Ahmed, M. B., Jazia, I. B., Slama, A. B., Baccouhe, A., Jemaa, A., & Ghédira, I. (2018) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000564 · Cited by 2
Tanaka, A., Leung, P. S. C., Bowlus, C. L., & Gershwin, M. E. (2020) · Springer eBooks · doi:10.1007/978-3-030-51709-0_22 · Cited by 2
Self-citationGeoepidemiology and the Impact of Sex on Autoimmune Diseases
Lleò, A. (2017) · Principles of Gender-Specific Medicine · doi:10.1016/b978-0-12-803506-1.00022-x · Cited by 3
Henriksson, I., Udumyan, R., Nilsson, E., Önnerhag, K., Rorsman, F., Werner, M., Marschall, H., Wåhlin, S., Nyhlin, N., & SweHep (2022) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2022.2103729 · Cited by 2
Rigamonti, C., Benedittis, C. D., Labanca, S., Vanni, E., Morgando, A., Manfredi, G. F., Azzolina, D., Cittone, M. G., Giannini, E. G., Saracco, G. M., et al. (2023) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002582 · Cited by 2
Floreani, A. (2021) · Springer eBooks · doi:10.1007/978-3-030-65908-0_8 · Cited by 2
Levy, C., Carrion, A. F., & Mayo, M. J. (2017) · Wiley eBooks · doi:10.1002/9781119251316.ch21 · Cited by 2
Primary Biliary Cholangitis, Liver Transplantation, and Hepatocellular Carcinoma: A Mini-review
Rawashdeh, B., Couillard, A. B., Rawshdeh, A., Aziz, H., Esteban, J. P., & Selim, M. A. (2022) · Gene Expression · doi:10.14218/ge.2022.00016 · Cited by 1
Primary Sclerosing Cholangitis: Gender Effects in Valencia’s Low-Prevalence Region
Mínguez, A., Conde, I., Montón, C., González, L. G., Pascual, S., Antón, M. D., Palau, A., Forés, A., Gisbert, C., Ojeda, A., et al. (2024) · Digestive Diseases and Sciences · doi:10.1007/s10620-024-08368-y · Cited by 1
“Sex plays an important role in the epidemiology, course, and response to treatment of autoimmune diseases [10–13].”
Chang, M., Cheng, J., Le, P., Chen, W., Ku, H., & Chien, R. (2024) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848241241227 · Cited by 1
“4 Consistent with these findings, a recent European study also reported that AMA-positive subjects without evidence of PBC were slightly younger and had a lower sex ratio imbalance than those newly diagnosed with PBC. 9 Moreover, 18.2% of journals.sagepub.com/home/tag”
BackgroundInfluentialLiu, J., Zhang, W., Xu, B., Ren, D., & Zhao, Y. (2025) · Cureus · doi:10.7759/cureus.89942 · Cited by 1
“It disproportionately affects women, with a 4:1 female-to-male incidence ratio [1].”
Optimizing Care in Primary Biliary Cholangitis: Current Treatments and the Second-Line Decision
Choi, G., Jesudian, A. B., & Saab, S. (2025) · Digestive Diseases and Sciences · doi:10.1007/s10620-025-09537-3 · Cited by 4
“In addition, men with PBC have higher mortality rates than women, possibly due to later diagnosis, as men are more likely to be asymptomatic, or due to a lower clinical suspicion of PBC in men among providers [16].”
Romeo, M., Nardo, F. D., Basile, C., Napolitano, C., Vaia, P., Martinelli, G., Gregorio, A. D., Puorto, L. D., Indipendente, M., Dallio, M., et al. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15120597 · Cited by 3
“…population-based study from Italy and Denmark showed that males had worse survival than females [HR for all-cause mortality 2.36 in the Italian and 3.04 in the Danish population], although a multivariable analysis with inclusion of liver biochemistry or disease severity was not performed [138].”
InfluentialRuiu, A., Calabrese, M. P., Meschisi, P., Plebani, R., Maria, B., Lleò, A., & Ronca, V. (2026) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2026.106883 · Cited by 1
Autoimmune Hepatitis and Immune-Mediated Cholestatic Liver Diseases
Czaja, A. J. (2018) · Springer eBooks · doi:10.1007/978-3-319-94355-8_16 · Cited by 2
Colangitis esclerosante primaria
Hurtado, A. J. A., Yánez, T. R., Martínez‐Ávila, M. C., Blanco, J. D. R., & Imbeth‐Acosta, P. L. (2021) · Hepatología · doi:10.52784/27112330.138 · Cited by 1
Kim, W. K. (2022) · Springer eBooks · doi:10.1007/978-981-19-0120-1_14 · Cited by 3
Rigopoulou, E. I., Koutsoumpas, A. L., & Bogdanos, D. P. (2022) · Springer eBooks · doi:10.1007/978-981-19-1946-6_6 · Cited by 1
Jin, Y., Wang, M., Liu, Y., & Xu, A. (2023) · Medicine · doi:10.1097/md.0000000000035617 · Cited by 3
“[1] PBC, considered as an autoimmune liver disease, is characterized by cholestasis, the presence of disease-specific autoantibodies including anti-mitochondrial antibodies, and histologic evidence of chronic nonsuppurative destructive cholangitis affecting small-or medium-size bile ducts.”
BackgroundTrivella, J. P., & Levy, C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-26710-9.00018-3 · Cited by 1
BeattieR.H.Sturrock, JenniferK.Rogers, RossSadler, BerneFerry, Roberts, C. A., RogerW.Chapman, & Lynch, K. D. (2018) · Journal of Gastroenterology and Hepatology Research · doi:10.17554/j.issn.2224-3992.2018.07.797 · Cited by 2
Saffioti, F., Thorburn, D., & Pinzani, M. (2020) · In clinical practice · doi:10.1007/978-3-030-53736-4_27 · Cited by 1
Tanaka, A., & Gershwin, M. E. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812102-3.00058-0 · Cited by 2
Self-citationLleò, A., & Hirschfield, G. M. (2021) · Hepatology · doi:10.1002/hep.31882 · Cited by 1
“Earlier epidemiological studies found that male sex was an independent predictor of mortality,(2) and the UK- PBC cohort demonstrated that male sex was associated with poor biochemical response.”
MethodCarey, E. J., & Levy, C. (2018) · Clinics in Liver Disease · doi:10.1016/s1089-3261(18)30044-8 · Cited by 1
张瑞敏, & 杨绵绵 (2012) · 书摘
Epidemiology of primary biliary cholangitis and its factors: An updated systematic reviewPreprint
Wu, N., Jin, R., Wang, X., Jiang, H.-J., Luo, B.-F., Song, G., & Feng, B. (2019) · Research Square · doi:10.21203/rs.2.14641/v1
“The lowest and highest incidence rates were found in New Zealand and Italy, respectively[12,19].”
BackgroundJohn, B. V., Dahman, B. A., Taddei, T. H., Levy, C., & Kaplan, D. E. (2021) · Hepatology · doi:10.1002/hep.31876
“PBC is more common in male individuals than previously believed.(3) We need more education, research, and dissemination of that research to raise awareness so that male individuals with PBC are diagnosed at an earlier stage.”
BackgroundClinical characteristics and prognosis of Primary biliary cholangitis with esophagogastric varices.Preprint
Zhang, M., Xie, H., Gerussi, A., Han, L., Chen, Y., Zhao, J., Liang, Q., Li, B., Invernizzi, P., Zou, Z., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1368857/v1
Self-citationLiver transplantation for primary biliary cholangitis (review)
Iljinsky, I. M., & Tsirulniкova, O. M. (2022) · Russian Journal of Transplantology and Artificial Organs · doi:10.15825/1995-1191-2022-1-15-22
Clinicopathological and Imaging Features of Primary Biliary CholangitisPreprint
Xie, M., Nyabanga, C. T. T., Sehmbhi, M., Khalili, N. A., Chon, C., Kamath, A., Dinani, A. M., & Weisberg, I. S. (2022) · medRxiv · doi:10.1101/2022.04.29.22274511
Challenges for diagnosis and treatment of primary biliary cholangitis
Tanaka, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85389-7.00007-7
Metabolomics-based Investigation of Primary Biliary Cholangitis: A Cholestatic Liver DiseasePreprint
de Oliveira, J. M., Lopes, T. D. A., Castro, A., Signini, É. D. F., Catai, A. M., Ferreira, A. G., Cançado, E. L. R., & Oliveira, R. V. (2024) · Research Square · doi:10.21203/rs.3.rs-3898120/v1 · Cited by 1
Managing Primary Biliary Cholangitis
Trivella, J. P. (2023) · Springer eBooks · doi:10.1007/978-3-031-48949-5_84
Roberts, E. (2024) · EMJ Hepatology · doi:10.33590/emjhepatol/pgqp6795
Khakoo, N. S., & Levy, C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23947-2.00039-4
Primary biliary cholangitis, a rising health burden
Elnaggar, M., Elkhattib, I., Abomhya, A., & Boyer, J. L. (2024) · Exploration of Immunology · doi:10.37349/ei.2024.00165 · Cited by 1
Iqirvo for primary biliary cholangitis – efficacy, safety, and future directions
Saleem, R., Shakeel, A., Riaz, R., Noman, F., & Nasser, N. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000003183 · Cited by 1
“Nonetheless, the overall mortality rate for male patients is considerably greater [ 3 ] Worldwide, incidence and prevalence of PBC were 1.76 and 14.60 per 100 000 individuals respectively.”
InfluentialTriple Threat: The Importance of Diagnosing “Triple-Negative” Primary Biliary Cholangitis
Mazhuvanchery, C. B., Indulkar, S. T., Triadafilopoulos, G., & Zhang, H. C. (2025) · Digestive Diseases and Sciences · doi:10.1007/s10620-025-09134-4
Nouvelles pistes thérapeutiques pour le traitement de la cholangite biliaire primitive
Brice, C., & Louvet, A. (2025) · médecine/sciences · doi:10.1051/medsci/2025109
Liu, C., Bai, Y.-F., Qin, W.-X., Zhang, W., & Cheng, J.-M. (2025) · International Journal of Biomedical Science and Engineering · doi:10.11648/j.ijbse.20251303.15
The impact of male sex on outcomes in primary biliary cholangitis
Walia, N., Pohl, J., Reinhardt, M., Pavlidis, C., French, J., Demir, M., Tacke, F., & Engelmann, C. (2026) · Scientific Reports · doi:10.1038/s41598-026-44615-0 · Cited by 2
Méndez‐Sánchez, N., Ramírez-Mejía, M. M., Cortez-Hernández, C., Tovar-Bojorquez, E. M., Contreras-Omaña, R., Monsiváis-Morales, J. D., Cordova-Gallardo, J., Castillo-Barradas, M., Guzmán-Rodríguez, N., González-Huezo, M. S., et al. (2026) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2026.02.003
Wong, R. J., Yang, Z., & Cheung, R. C. (2026) · Gastro Hep Advances · doi:10.1016/j.gastha.2026.100983
Ortega-Torres, A., Sánchez-Díaz, G., Villaverde‐Hueso, A., Arias-Merino, G., & Alonso‐Ferreira, V. (2026) · BMC Public Health · doi:10.1186/s12889-026-28178-3
“A breakdown by country shows that these differences are minimal in Romania (1:1) and greatest in Latvia and the UK (1:9 and 1:6, respectively in 2012–2022) [17].”
Ronconi, G., Dondi, L., Ambrosio, N., Calabria, S., Maverna, G., Acciai, V., Buttiglione, V., Invernizzi, P., Gentilucci, U. V., Carbone, M., et al. (2026) · Global & Regional Health Technology Assessment · doi:10.33393/grhta.2026.3767
Self-citationCharacterization of a Northern German Primary Biliary Cholangitis Cohort
Bantel, H., Kader, Y. F., John, K., Franck, M., & Wedemeyer, H. H. (2026) · Zeitschrift für Gastroenterologie · doi:10.1055/a-2857-7915
Cançado, G. G. L., Couto, C. A., Faria, L. C., Moraes, B. D. F., Leite, G. A. P. D., Bittencourt, P. L., Vilella-Nogueira, C. A., Rotman, V., Terrabuio, D. R. B., Cançado, E. L. R., et al. (2026) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2026.101622 · Cited by 2
Méndez‐Sánchez, N., Ramírez-Mejía, M. M., Cortez-Hernández, C., Tovar-Bojorquez, E. M., Contreras-Omaña, R., Monsiváis-Morales, J. D., Cordova-Gallardo, J., Castillo-Barradas, M., Guzmán-Rodríguez, N., González-Huezo, M. S., et al. (2026) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2026.02.003
Ejnisman, C., Pasini, B. A. V., Shiroma, H. S., Hirayama, A. B., Pasoto, S. G., & Franco, A. S. (2026) · Cureus · doi:10.7759/cureus.117335
“SjD has an estimated incidence of 3.5-3.9 per 100,000 person-years and a female-to-male ratio near 9:1 [15]; PBC is rarer, at approximately 1.76 per 100,000, with a female predominance of 4-6:1 [16,17].”
InfluentialSafety profile of elafibranor versus placebo in primary biliary cholangitis
Khan, N. A., Shahbaz, H., Talha, M., Khan, M. A., Tahir, M. A., Anwar, U., Khan, M. S., & Adhikari, P. (2026) · Medicine · doi:10.1097/md.0000000000051009
“[3,4] PBC is associated with significant mortality.”
Metadata
- Authors
- Lleo, A., Jepsen, P., Morenghi, E., Carbone, M., Moroni, L., Battezzati, P. M., Podda, M., Mackay, I. R., Gershwin, M. E., & Invernizzi, P.
- Affiliations
- Aarhus University Hospital (DK)
- Humanitas University (IT)
- University of Milan (IT)
- Monash University (AU)
- University of California, Davis (US)
- Corresponding author
- Gershwin, M. Eric
- Invernizzi, Pietro
- ORCID
- Venue
- Scientific Reports
- Published
- 2016-05-19
- Volume
- 6
- Issue
- 1
- Pages
- 25906-25906
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC4872151
- OpenAlex
- W2406168974
- Semantic Scholar
- 9001269fdc4d993a0ebe15ab73b40c226bf70629
- Cited by
- 186
- References
- 62
- Citations by year
- 2026: 12 · 2025: 23 · 2024: 17 · 2023: 29 · 2022: 17 · 2021: 18 · 2020: 15 · 2019: 16 · 2018: 19 · 2017: 17 · 2016: 1
- FWCI
- 12.78
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Monash University Research Portal (Monash University) (acceptedVersion, other-oa)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- BOA (University of Milano-Bicocca) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Health Sciences › Medicine › Rheumatology › IgG4-Related and Inflammatory Diseases
- Keywords
- primary biliary cirrhosis, sex ratio, incidence, prevalence, all-cause mortality, male mortality, sex differences, population-based registry, Lombardy, Denmark, cholestatic liver disease
- MeSH terms
- Denmark, Female, Humans, Italy, Liver Cirrhosis, Biliary, Male, Registries, Regression Analysis, Sex Characteristics, Incidence, Prevalence, Survival Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.